[1] Fudge N,Sadler E,Fisher HR,et al.Optimising Translational Research Opportunities: A Systematic Review and Narrative Synthesis of Basic and Clinician Scientists' Perspectives of Factors Which Enable or Hinder Translational Research. PloS one. 2016;11(8):e0160475.[2] Marjanovic S,Soper B,Ismail S,et al.Changing the Translational Research Landscape: A Review of the Impacts of Biomedical Research Units in England. Rand health quarterly.2012;1(4):12. [3] Sofaer N,Eyal N.Translational research beyond approval: a two-stage ethics review. The American journal of bioethics: AJOB. 2010;10(8):W1-3. [4] 姬小利,李倩,吕志宝,等. 精准医学背景下生物样本库发展中存在的问题及对策[J]. 中华医院管理杂志,2016,32(9):692-694. [5] Anandagoda N,Lord GM.Boosting translational research in the U.K. Science translational medicine.2016;8(357):357fs15.[6] Kimmelman J, Kesselheim AS. Translational research and the U.S. federal elections. Science translational medicine. 2016;8(361):361ed13. [7] 阴赪宏,孙芳芳,齐海宇,等.以转化医学理念指导临床科学研究[J]. 医学研究杂志, 2011,40(1):23-5. [8] 赵玉沛.加快转化医学发展,促进医学模式转变[J].中华医学杂志, 2011, 91(4):217-9. [9] [No authors listed] .Perspectives in Translational Research in Life Sciences and Biomedicine. Anticancer research. 2016;36(8):4373. [10] 张鹏,秦岭. 转化医学:基础医学与临床医学实践的桥梁[J].实用医学杂志, 2010;26(18):3277-3279. [11] 时占祥,詹启敏,顾申,等. 转化医学在中国:五年回顾与展望[J].科学通报, 2015,(22):2151-2156. [12] 吴静,顾怡珺,周君梅. 我院生物样本库“一病一卡”管理制度的建立与应用[J]. 中华医院管理杂志,2013,29(11):866-867. [13] Meir K, Gaffney EF, Simeon-Dubach D, et al.The Marble Arch International Working Group On Biobanking MM. The human face of biobank networks for translational research. Biopreserv Biobank. 2011;9(3):279-285. [14] Lassalle S,Hofman V,Ilie M,et al. Setting up a Prospective Thyroid Biobank for Translational Research: Practical Approach of a Single Institution (2004-2009, Pasteur Hospital, Nice, France). Biopreserv Biobank. 2011;9(1):9-19. [15] 陆怡. 转化医学与生物样本库现状[J].生命的化学,2012,32(3):287-293. [16] 董哲君,肖飞,郭健.生物样本库建立现况及进展[J].中华检验医学杂志, 2013,36(2):130-135. [17] 刘克新,郑琳,王莹, 等.生物样本库的现状及研究进展[J].中国病案, 2014, 15(9):32-34. [18] 张雪娇,李海燕,龚树生.国内生物样本库建设现状分析与对策探讨[J].中国医院管理, 2013,33(7):76-77. [19] 李昆. 临床病例生物样本库建设及其面临的医学伦理问题[J]. 西南军医, 2015,17(6):696-698. [20] Saha K, Hurlbut JB. Research ethics: Treat donors as partners in biobank research. Nature.2011;478(7369):312-313.[21] Wolf SM. Return of results in genomic biobank research: ethics matters. Genet Med. 2013;15(2):157-159.[22] 胡庆澧.上海重大疾病临床样本库伦理管理指南[J].中国生物样本库国际研讨会暨中国生物样本库发展战略高峰论坛,2013.[23] 丁桂龄,何妙侠,郑建明.临床生物样本库的建立、管理与质量控制[J].临床与实验病理学杂志,2015,31(11):1301-1303. [24] 张育军,高芳芳,彭卫康,等.生物样本库质量控制体系建立的经验和体会[J].转化医学杂志,2014(3):170-173. [25] 胡颖,张连海,宋丽洁, 等.生物样本质量的影响因素与评估[J].中国医药生物技术, 2013,8(1):69-72. [26] 中国医药生物技术协会生物样本库标准(试行) [J]. 中国医药生物技术, 2011(1):71-79. [27] 蒋超,曹日昇,陈俊娣,等. 生物样本库样本质量控制体系建立的初步探索[J].江苏医药,2016,42(2):198-200. [28] Forster JL, Harkin VB, Graham DA, et al. The effect of sample type, temperature and RNAlater on the stability of avian influenza virus RNA. J Virol Methods. 2008;149(1):190-194. [29] Medeiros M, Sharma VK, Ding R,et al. Optimization of RNA yield, purity and mRNA copy number by treatment of urine cell pellets with RNAlater. J Immunol Methods. 2003;279(1-2):135-142. [30] 隋鑫. 生物样本库质量控制体系的构建研究[J].科学与财富, 2015,(18): 120. [31] 姚静怡,杨爱婷, 李秀红,等.样本库质量控制评估体系的建立[J]. 临床和实验医学杂志,2015,14(21):1758-1760. [32] 阮亮亮,郑培永,杨佳泓,等.生物样本库RNA质量控制的方法学验证[J]. 转化医学杂志, 2015,4(3):161-165. [33] Campbell LD, Betsou F, Garcia DL, et al. Development of the ISBER Best Practices for Repositories: Collection, Storage, Retrieval and Distribution of Biological Materials for Research. Biopreserv Biobank. 2012;10(2):232-233. [34] Auer H, Mobley JA, Ayers LW,et al. The effects of frozen tissue storage conditions on the integrity of RNA and protein. Biotech Histochem. 2014; 89(7):518-528. [35] Chu TY, Hwang KS, Yu MH,et al. A research-based tumor tissue bank of gynecologic oncology: characteristics of nucleic acids extracted from normal and tumor tissues from different sites. Int J Gynecol Cancer. 2002;12(2):171-176. [36] 郭爱华,张翠,余永国,等.二维码技术在生物样本库编码中的应用与评价[J].中国医药生物技术,2012,7(4):306-308. [37] 王琼,邹宇辉,林春发,等.医院生物样本库管理系统[C].2014中华医院信息网络大会,2014.[38] 俞红,王从容.生物样本库信息管理系统的设计和实现[J].中国数字医学, 2013,(10):79-81. [39] 唐密. 生物样本库共享理论与实证研究[D].复旦大学,2014.[40] Akervall J,Pruetz BL,Geddes TJ,et al.Beaumont health system biobank: a multidisciplinary biorepository and translational research facility. Biopreserv Biobank.2013;11(4):221-228.[41] 樊光辉.聚力推进转化医学创新发展[J].转化医学电子杂志, 2016,3(1): 1-4. |